ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,662.38
1.23%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Atossa Therapeutics Inc (ATOS)

  7. Atossa Therapeutics Inc (ATOS) Noticias

ATOS Atossa Therapeutics Inc

1.66
0.14 (9.21%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Atossa Therapeutics Inc ATOS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.14 9.21% 1.66 15:55:25
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.53 1.53 1.70 1.66 1.52
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202407:30GLOBEAtossa Therapeutics Announces Expanded Research Agreement..
15/4/202407:30GLOBEAtossa Therapeutics and Quantum Leap Healthcare Announce..
11/4/202407:30GLOBEAtossa to Participate in Noble Capital Markets Emerging..
09/4/202410:59GLOBEAtossa Therapeutics Presents Data from 40mg Cohort of Phase..
01/4/202415:00GLOBEAtossa Therapeutics Announces Year-End 2023 Financial..
19/3/202407:30GLOBEAtossa Therapeutics Provides Five-Year (Z)-Endoxifen..
18/3/202407:30GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
12/3/202407:30GLOBEAtossa Therapeutics Appoints Breast Cancer Specialist Tessa..
22/2/202407:30GLOBEAtossa Therapeutics Announces First Patient Dosing of..
07/2/202407:30GLOBEAtossa Therapeutics Announces Full Enrollment..
09/1/202407:30GLOBEAtossa Therapeutics Issues Letter to Shareholders
04/12/202307:30GLOBEAtossa Therapeutics Announces the Appointment of Arezoo..
20/11/202307:30GLOBEAtossa Therapeutics Announces Full Enrollment of Phase 2..
15/11/202316:03EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15/11/202315:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/11/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202308:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202308:00EDGAR2Form 8-K - Current report
13/11/202308:00GLOBEAtossa Therapeutics Announces Third Quarter 2023 Financial..
09/11/202308:00EDGAR2Form 8-K - Current report
09/11/202308:00GLOBEAtossa Therapeutics Appoints Financial Executive Jonathan..
30/10/202312:00PRNUSQuantum Leap Healthcare Collaborative Initiates Landmark..
16/10/202315:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/10/202307:30PRNUSFast-food consumption by adolescent girls may sow the seeds..
06/10/202315:00EDGAR2Form 8-K - Current report
28/9/202315:28EDGAR2Form 8-K - Current report
18/9/202307:30GLOBEAtossa to Present at Cantor Fitzgerald Global Healthcare..
14/8/202307:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202307:30EDGAR2Form 8-K - Current report
14/8/202307:30GLOBEAtossa Therapeutics Announces Second Quarter 2023 Financial..
08/8/202308:00GLOBEAtossa Therapeutics to Provide Business Update and Report..
20/7/202308:15GLOBEAtossa Therapeutics Receives Approval from Health Canada to..
13/7/202315:20EDGAR2Form 8-K - Current report
13/7/202315:15GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
10/7/202308:15GLOBEAtossa Therapeutics Provides Enrollment Update for Ongoing..
06/7/202308:15GLOBEAtossa Therapeutics Announces Sponsored Research Agreement..
28/6/202308:15GLOBEAtossa Therapeutics and Quantum Leap Healthcare Provide..
28/6/202308:01EDGAR2Form 8-K - Current report
27/6/202308:15GLOBEAtossa Therapeutics Announces $10M Stock Repurchase Program
22/6/202315:15GLOBEAtossa Therapeutics Announces Sponsorship of Are You Dense..
21/6/202309:13GLOBEAtossa Therapeutics Granted Additional Patent Protection for..
14/6/202308:15GLOBEAtossa to Participate in Fireside Chat at Healthcare Virtual..
12/6/202308:15GLOBEAtossa Completes Enrollment of Pharmacokinetic Run-In Cohort..
01/6/202308:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
23/5/202306:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
15/5/202308:10GLOBEAtossa Therapeutics Announces First Quarter 2023 Financial..
11/5/202308:00PRNUSPhysician-Scientist Dr. Steven Quay Provides Recommendations..
09/5/202308:15GLOBEAtossa to Present a Trial in Progress Poster on its..

Su Consulta Reciente

NASDAQ
ATOS
Atossa Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados